東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

FindBook

Google Book

Amazon

博客來

Targeting oncogenic driver mutations in lung cancer

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Targeting oncogenic driver mutations in lung cancer/ Matthew Lee ... [et al.].
其他作者:	Lee, Matthew Allen,
出版者:	Cambridge :Cambridge University Press, : 2023.,
面頁冊數:	87 p. :ill., digital ;23 cm.
附註:	Also issued in print: 2023.
標題:	Lungs - Cancer -
電子資源:	https://doi.org/10.1017/9781009336123
ISBN:	9781009336123

Targeting oncogenic driver mutations in lung cancer
Targeting oncogenic driver mutations in lung cancer[electronic resource] /Matthew Lee ... [et al.]. - Cambridge :Cambridge University Press,2023. - 87 p. :ill., digital ;23 cm. - Cambridge elements. Elements in molecular oncology. - Cambridge elements.Elements in molecular oncology..

Also issued in print: 2023.

Includes bibliographical references.

The recent advances in the field of molecular diagnostic techniques have led to the identification of targetable alterations prompting a paradigm shift in the management of non-small cell lung cancer (NSCLC) and an era of precision oncology. This text highlights the most clinically relevant oncogenic drivers other than EGFR, their management and current advancements in treatment. It also examines the different challenges in resistance to targeted therapies and diagnostic dilemmas for each oncogenic driver and the future direction of NSCLC management.

Specialized.

ISBN: 9781009336123

Standard No.: 10.1017/9781009336123doiSubjects--Topical Terms:

2017391
Lungs
--Cancer

LC Class. No.: RC280.L8 / L4 2023

Dewey Class. No.: 616.99424

National Library of Medicine Call No.: WF 658

Targeting oncogenic driver mutations in lung cancer
LDR:01671nmm a2200325 a 4500 001 2378148
003 StDuBDS
005 20230131124228.0
006 m d
007 cr nn 008maaau
008 250304s2023 enka fob 000 0 eng d
020 $a 9781009336123 $q (electronic bk.)
020 $a 9781009336130 $q (paperback)
024 7 $a 10.1017/9781009336123 $2 doi
035 $a CR9781009336123
040 $a StDuBDS $b eng $c StDuBDS $d GP
041 0 $a eng
050 4 $a RC280.L8 $b L4 2023
060 4 $a WF 658
082 0 4 $a 616.99424 $2 23
090 $a RC280.L8 $b L479 2023
245 0 0 $a Targeting oncogenic driver mutations in lung cancer $h [electronic resource] / $c Matthew Lee ... [et al.].
260 $a Cambridge : $b Cambridge University Press, $c 2023.
300 $a 87 p. : $b ill., digital ; $c 23 cm.
490 1 $a Cambridge elements. Elements in molecular oncology
500 $a Also issued in print: 2023.
504 $a Includes bibliographical references.
520 8 $a The recent advances in the field of molecular diagnostic techniques have led to the identification of targetable alterations prompting a paradigm shift in the management of non-small cell lung cancer (NSCLC) and an era of precision oncology. This text highlights the most clinically relevant oncogenic drivers other than EGFR, their management and current advancements in treatment. It also examines the different challenges in resistance to targeted therapies and diagnostic dilemmas for each oncogenic driver and the future direction of NSCLC management.
521 $a Specialized.
588 $a Description based on online resource; title from PDF title page (viewed on January 26, 2023).
650 0 $a Lungs $x Cancer $x Treatment. $3 2017391
650 0 $a Cancer $x Molecular aspects. $3 661419
700 1 $a Lee, Matthew Allen, $d 1980- $3 3729280
830 0 $a Cambridge elements. $p Elements in molecular oncology. $3 3729281
856 4 0 $u https://doi.org/10.1017/9781009336123